This inventor holds 1 USPTO granted patent. Top assignee: Novozymes A/s. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Lars Henrik Oestegaard: Innovator in DNase Variants
Introduction
Lars Henrik Oestegaard is a notable inventor based in Charlottelund, Denmark. He has made significant contributions to the field of biotechnology, particularly through his work on DNase variants. His innovative approach has led to advancements in the understanding and application of polypeptide variants.
Latest Patents
Lars holds 1 patent related to DNase variants. The present invention pertains to polypeptide variants and methods for obtaining these variants. It also encompasses polynucleotides encoding the variants, nucleic acid constructs, vectors, and host cells that comprise the polynucleotides. Furthermore, the invention includes methods of utilizing these variants effectively.
Career Highlights
Lars Henrik Oestegaard is associated with Novozymes A/S, a leading company in the biotechnology sector. His work at Novozymes has allowed him to focus on innovative solutions that enhance the efficacy of biotechnological applications.
Collaborations
Throughout his career, Lars has collaborated with esteemed colleagues such as Gernot J Abel and Annette Helle Johansen. These collaborations have fostered a productive environment for innovation and research.
Conclusion
Lars Henrik Oestegaard's contributions to the field of biotechnology, particularly through his patent on DNase variants, highlight his role as an influential inventor. His work continues to impact the industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile